Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort

Michael D. Miedema, Faye L. Lopez, Michael J. Blaha, Salim S. Virani, Josef Coresh, Christie M. Ballantyne, Aaron R. Folsom

Research output: Contribution to journalLetter

Fingerprint Dive into the research topics of 'Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older us cohort: The atherosclerosis risk in communities study cohort'. Together they form a unique fingerprint.